Antibiotics (Nov 2023)

Methicillin Resistance Increased the Risk of Treatment Failure in Native Joint Septic Arthritis Caused by <i>Staphylococcus aureus</i>

  • Jungok Kim,
  • So Yeon Park,
  • Kyung Mok Sohn,
  • Bomi Kim,
  • Eun-Jeong Joo

DOI
https://doi.org/10.3390/antibiotics12111628
Journal volume & issue
Vol. 12, no. 11
p. 1628

Abstract

Read online

This study aimed to compare clinical characteristics and outcomes in patients with native joint septic arthritis (NJSA) due to methicillin-resistant Staphylococcus aureus (MRSA) in comparison to methicillin-sensitive S. aureus (MSSA) and identify treatment failure risk factors. We conducted a multi-center retrospective study on adult NJSA patients at three teaching hospitals in South Korea from 2005 to 2017. Among 101 patients diagnosed with S. aureus NJSA, 39 (38.6%) had MRSA strains. Compared to MSSA, patients with MRSA had a higher prevalence of nosocomial infections (17.9% vs. 1.6%; p = 0.005) and received inappropriate antibiotics within 48 h more frequently (74.4% vs. 0%; p p = 0.007) with a notably increased frequency of requiring repeated surgical interventions after 30 days of antibiotic therapy (17.9% vs. 3.2%, p = 0.026), in contrast to the MSSA group. Independent risk factors for treatment failure included Charlson comorbidity score, elevated CRP levels, and methicillin resistance. Methicillin resistance is an independent risk factor for treatment failure, emphasizing the need for vigilant monitoring and targeted interventions in MRSA-related NJSA cases.

Keywords